Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2000
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/29/2000CN1275060A Liver function test
11/28/2000US6153775 Polydentate imines and their metal complexes
11/28/2000US6153771 Intermediates for the preparation of iodinated contrast agents
11/28/2000US6153639 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative
11/28/2000US6153598 Acts as synthetic vector for achieving efficient transfection of associated nucleic acid into a cell; gene therapy
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153172 Reflective microspheres for ultrasonic imaging
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/23/2000WO2000069474A1 Methods for treating avm' using radioactive compositions
11/23/2000WO2000069473A2 Macromolecular carrier for drug and diagnostic agent delivery
11/23/2000WO2000069451A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000WO2000016811A3 Mri contrast agent
11/23/2000CA2373935A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000CA2369983A1 Methods for treating avm's using radioactive compositions
11/22/2000EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation
11/22/2000EP1053747A2 Composition for treating topical periodontal infection
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053027A1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi
11/22/2000EP1053026A1 Contrast medium based on polyoxethylene-660-12-hydroxystearate and anionic phospholipids
11/21/2000US6150583 Transgenic animals expressing artificial epitope-tagged proteins
11/21/2000US6150516 Solid phase supports, each having spatially discrete regions, each region having uniform population of identical tag complements selected from single mimimally cross-hybridizing set of oligonucleotides; large scale sequencing and analysis
11/21/2000US6150327 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/21/2000US6149903 Suppressing the growth of an epithelial ovarian tumor in a mammal by injecting a genetic engineered vector to an intraperitoneal cavity of the mammal at the site of tumor
11/21/2000US6149891 Intravenous injectable mixture comprising radiology contrast agent and a cytoprotective agent which induces cells to generate nitric oxide to protect against damage by contrast agent; side effect reduction
11/21/2000US6149890 Chelated complexes of paramagnetic metals with low toxicity
11/21/2000CA2127705C Improvements in or relating to contrast agents
11/21/2000CA2105502C Insulin secretion stimulating composition for the treatment of non-insulin-dependent diabetes
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000038536A3 Inhibitors of the bitter taste response
11/16/2000WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/15/2000EP1051602A2 Process and device to solidify and thaw a polarized gas comprising xenon
11/15/2000EP1051421A1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy
11/15/2000EP1051195A1 Identification of agents that protect against inflammatory injury to neurons
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000EP0714402B1 Polymer modification
11/14/2000US6146657 Liposome filled with an insoluble gas and a soluble gas, wherein said liposome comprises phosphatidylcholine(s), phosphatidylethanolamine(s), and phosphatidic acid(s); use in ultrasonic or magnetic resonance imaging
11/14/2000US6146645 Uses of oil bodies
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146615 A compound capable of complexing with paramagnetic fe(iii) ion useful as a tissue-specific contrast agent for image enhancement of tissue
11/14/2000US6146614 Administering a labeled ligand to mammal under conditions interact with lymphocytes to form the labeled lymphocytes; for diagnosing the degree of progression of a disease, monitoring the therapy response
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066544A1 Contrast media
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066180A2 Method for enhancing contrast produced by mri
11/09/2000WO2000065938A1 Supplementary drinks used in the diagnosis of diabetes
11/09/2000WO2000035488A3 Vitronectin receptor antagonist pharmaceuticals
11/09/2000WO2000030688A3 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/09/2000WO2000020042A9 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
11/09/2000DE19917347A1 Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe Method and apparatus for applying dry substances on inhalable pulverulent carrier substances
11/09/2000CA2372235A1 Conserved neisserial antigens
11/09/2000CA2368748A1 X-ray guided drug delivery
11/08/2000EP1049767A1 A transgenic rabbit that expresses a functional human lipoprotein (a)
11/08/2000EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin
11/08/2000EP0812422B1 Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
11/08/2000EP0727959A4 Diagnostic uses of hydrazinoadenosines
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/07/2000US6143558 Cells containing at least one fiberless optical sensor of a solid particle from 1 micrometer to 1 nanometer in diameter and having one or more active sensor molecules imbedded in particle; nontoxic monitoring at several locations in a cell
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6143274 Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
11/07/2000US6142939 Microporation of human skin for drug delivery and monitoring applications
11/07/2000CA2037933C Method of treatment with medical agents
11/02/2000WO2000065346A1 Diagnosis of human kidney diseases
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000064492A1 Apparatus for optically monitoring concentration of a bioanalyte in blood and related methods
11/02/2000WO2000064491A1 4-fluoroalkyl-3-halophenyl nortropanes
11/02/2000WO2000064480A1 Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
11/02/2000EP1047677A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047455A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
11/02/2000EP1047454A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/02/2000EP0586524B2 Improvements in or relating to contrast agents
11/02/2000CA2371242A1 Diagnosis of human kidney diseases
11/02/2000CA2369663A1 4-fluoroalkyl-3-halophenyl nortropanes
11/01/2000CN1272218A Retentate chromatography and protein chip arrays with applications in biology and medicine
11/01/2000CN1272058A Perforated microparticles and methods of use
10/2000
10/31/2000USRE36939 A booster comprising a plenty of microbubbles of a gas and drug in a liquid, diffusion and penetration of the medicament into the body by applying ultrasound; transdermal drug delivery
10/31/2000US6140314 Selective and non-invasive visualization or treatment of vasculature
10/31/2000US6139819 Comprising lipid, protein, polymer and/or surfactant, and a gas, in combination with a targeting ligand; targeting ligand targets coagula, including emboli and/or thrombi, particularly in patients suffering from arrhythmic disorder
10/31/2000US6139818 Method of making ultrasonic contrast agent
10/31/2000CA2121377C Altered dipole moment magnetic resonance imaging method
10/26/2000WO2000063699A1 A tenascin-c isoform as a marker for neoplasias
10/26/2000WO2000063296A2 Cyanine dyes and synthesis methods thereof
10/26/2000WO2000062819A1 Formulations for detecting asthma
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000025671A9 Manganese compositions and methods for mri
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2335240A1 Cyanine dyes and synthesis methods thereof
10/25/2000EP1046051A1 Method of magnetic resonance investigation
10/25/2000EP1045851A1 Substituted porphyrins
10/25/2000EP1045838A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
10/25/2000EP0717617B1 Active principle and gas containing microparticles
10/25/2000CN1057703C Method for preparing contrast media
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 354